Stay updated on Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Publication entry for SERENA-2 (Lancet Oncol. 2024) and its erratum added; the entry revision updated from v3.4.2 to v3.4.3 to reflect this change.
    Difference
    0.1%
    Check dated 2026-03-07T13:00:44.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    - Page revision updated from v3.4.1 to v3.4.2. No substantive changes to core study details were observed.
    Difference
    0.0%
    Check dated 2026-02-14T04:37:16.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.4.0 to v3.4.1, with no visible changes to study information.
    Difference
    0.0%
    Check dated 2026-02-07T05:06:27.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The updates are minor UI and metadata adjustments, including a glossary option being shown, updates to Last Update Submitted that Met QC Criteria and Last Update Posted, and the revision label updated to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-23T21:55:18.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    System revision updated from v3.3.3 to v3.3.4; no changes to study details, eligibility criteria, or results are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T23:53:32.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Locations section updated with new sites (Alabama, California, Florida, Nebraska, Ohio, Tennessee, Wisconsin, and Quebec) and removal of existing sites. Revision: v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-19T05:47:25.000Z thumbnail image

Stay in the know with updates to Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.